Drug Trial Radar · NCT06588153
A Study for the Evaluation of Efficacy and Safety of Prolia® in Participants With Glucocorticoid-induced Osteoporosis in Mainland China
Last checked: Nov 20, 2026Latest source record: May 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
102
Actual
Start
May 24, 2025
Primary completion
Apr 27, 2027
Study completion Apr 27, 2027
Sponsor
- Lead sponsor
- AmgenAmgen (AMGN)
- Sponsor type
- Industry
- First posted
- Sep 19, 2024
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The main objective of this study is to evaluate the efficacy of Prolia® in improving bone mass density (BMD) of lumbar spine at month 12.
Conditions
- Glucocorticoid-induced Osteoporosis
Interventions
Prolia®Drug
Subcutaneous (SC) injection in pre-filled syringe.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from Baseline in Lumbar Spine BMD PercentageTime frame: At 12 months
Locations
16 sites in 1 country. Site status is shown where the registry gives one.
Sichuan Provincial Peoples Hospital
Chengdu, China
Beijing Friendship Hospital, Capital Medical University
Beijing, Beijing Municipality, China
Guangzhou First Peoples Hospital
Guangzhou, Guangdong, China
Nanfang Hospital Southern Medical University
Guangzhou, Guangdong, China
Shenzhen Peoples Hospital
Shenzhen, Guangdong, China
The First Affiliated Hospital of Henan University of Science and Technology
Luoyang, Henan, China
Union Hospital Tongji Medical College Huazhong University of Science and Technology
Wuhan, Hubei, China
The First Peoples Hospital of Changzhou
Changzhou, Jiangsu, China
Huaian First Peoples Hospital
Huaian, Jiangsu, China
Affiliated Hospital of Nantong University
Nantong, Jiangsu, China
Pingxiang Peoples Hospital
Pingxiang, Jiangxi, China
The First Bethune Hospital of Jilin University
Changchun, Jilin, China
The First Affiliated Hospital of Xi An Jiaotong University
Xi'an, Shaanxi, China
Shanghai Guanghua Hospital of Integrated Traditional Chinese and Western Medicine
Shanghai, Shanghai Municipality, China
First Hospital of Shanxi Medical University
Taiyuan, Shanxi, China
Zhejiang Provincial Peoples Hospital
Hangzhou, Zhejiang, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.